Bvf Inc Infinity Pharmaceuticals, Inc. Transaction History

Bvf Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$1.86 - $3.36 $3.78 Million - $6.82 Million	-2,030,000 Reduced 24.21%	6,353,645 $14.3 Million
Q1 2021 May 17, 2021	SELL	$1.98 - $5.36 $17.9 Million - $48.5 Million	-9,043,323 Reduced 51.89%	8,383,645 $27.1 Million
Q4 2018 Feb 14, 2019	BUY	$1.01 - $2.78 $2.22 Million - $6.1 Million	2,194,700 Added 14.41%	17,426,968 $20.6 Million
Q2 2018 Aug 14, 2018	BUY	$1.72 - $2.26 $9.4 Million - $12.4 Million	5,465,760 Added 55.96%	15,232,268 $29.1 Million
Q4 2017 Feb 14, 2018	BUY	$1.22 - $3.73 $2.32 Million - $7.09 Million	1,900,400 Added 24.16%	9,766,508 $19.8 Million
Q3 2017 Nov 14, 2017	BUY	$0.94 - $1.35 $7.39 Million - $10.6 Million	7,866,108	7,866,108 $10.5 Million

1.26M

Ticker INFI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 89,277,904
Description
Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of met...

Get notified when there are updates to the investment portfolio of Bvf Inc, based on Form 13F filings with the SEC.

Stay updated on Bvf Inc with notifications on news.